Nitchem Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 4.51 Cr
as on 29-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -33.03%
(FY 2022)
- Profit -46.36%
(FY 2022)
- Ebitda 93.35%
(FY 2022)
- Net Worth 12.15%
(FY 2022)
- Total Assets -15.21%
(FY 2022)
About Nitchem Lifesciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chetan Sobti, Nitin Sobti, and Aradhana Sobti serve as directors at the Company.
- CIN/LLPIN
U24239HR2017PTC070706
- Company No.
070706
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nitchem Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Sobti  | Additional Director | 15-Nov-2024 | Current |
| Chetan Sobti | Additional Director | 15-Nov-2024 | Current |
| Aradhana Sobti | Director | 06-May-2023 | Current |
Financial Performance of Nitchem Lifesciences.
Nitchem Lifesciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.03% decrease. The company also saw a substantial fall in profitability, with a 46.36% decrease in profit. The company's net worth Soared by an impressive increase of 12.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nitchem Lifesciences?
Unlock access to Nitchem Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nichepharm Lifesciences Private LimitedActive 5 years 3 monthsChetan Sobti and Nitin Sobti are mutual person
Carewell Pharmapack International Private LimitedActive 4 years 11 monthsChetan Sobti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nitchem Lifesciences?
Unlock and access historical data on people associated with Nitchem Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nitchem Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nitchem Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
